Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China

Our study aims to identify the clinical breakpoints (CBPs) of second-line drugs (SLDs) above which standard therapy fails in order to improve multidrug-resistant tuberculosis (MDR-TB) treatment. MICs of SLDs were determined for M. tuberculosis isolates cultured from 207 MDR-TB patients in a prospect...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Antimicrob Agents Chemother
Main Authors: Zheng, Xubin, Zheng, Rongrong, Hu, Yi, Werngren, Jim, Forsman, Lina Davies, Mansjö, Mikael, Xu, Biao, Hoffner, Sven
Format: Artigo
Sprog:Inglês
Udgivet: American Society for Microbiology 2016
Fag:
Clinical Therapeutics
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4958164/
https://ncbi.nlm.nih.gov/pubmed/27246779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03008-15
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker